| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $471,208 ) |
| | 2022 | 2022 | TEL AVIV UNIVERSITY | 55 LEBANON HAIM | TEL AVIV-JAFFA | | | | ISR | R01DC011835 | Genomic Approaches to Discovery and Characterization of Genes for Inherited Hearing Loss | 000 | 10 | NIH | 6/1/2022 | $471,178 |
| | 2022 | 2019 | TEL AVIV UNIVERSITY | 55 LEBANON HAIM | TEL AVIV-JAFFA | | | | ISR | R21EY029450 | Selective Optogenetic Inhibition of Neuropeptide Release | 000 | 2 | NIH | 1/13/2022 | $0 |
| | 2022 | 2017 | TEL AVIV UNIVERSITY | 55 LEBANON HAIM | TEL AVIV-JAFFA | | | | ISR | R01CA172138 | STRESS UNDERMINES IMMUNE STIMULATION: MECHANISMS & BIOLOGICAL SIGNIFICANCE | 000 | 5 | NIH | 9/26/2022 | $30 |
|
| Issue Date FY: 2021 ( Subtotal = $478,671 ) |
| | 2021 | 2021 | TEL AVIV UNIVERSITY | 55 LEBANON HAIM | TEL AVIV-JAFFA | | | | ISR | R01DC011835 | Genomic Approaches to Discovery and Characterization of Genes for Inherited Hearing Loss | 000 | 9 | NIH | 6/2/2021 | $478,671 |
|
| Issue Date FY: 2020 ( Subtotal = $476,016 ) |
| | 2020 | 2020 | TEL AVIV UNIVERSITY | 55 LEBANON HAIM | TEL AVIV-JAFFA | | 006905904 | | ISR | R01DC011835 | Genomic Approaches to Discovery and Characterization of Genes for Inherited Hearing Loss | 000 | 8 | NIH | 5/21/2020 | $483,903 |
| | 2020 | 2017 | TEL AVIV UNIVERSITY | 55 LEBANON HAIM | TEL AVIV-JAFFA | | 006905904 | | ISR | R01CA172138 | STRESS UNDERMINES IMMUNE STIMULATION: MECHANISMS & BIOLOGICAL SIGNIFICANCE | 000 | 5 | NIH | 1/2/2020 | -$7,887 |
|
| Issue Date FY: 2019 ( Subtotal = $639,989 ) |
| | 2019 | 2019 | TEL AVIV UNIVERSITY | 55 LEBANON HAIM | TEL AVIV-JAFFA | | 006905904 | | ISR | R21EY029450 | Selective Optogenetic Inhibition of Neuropeptide Release | 000 | 2 | NIH | 8/12/2019 | $149,849 |
| | 2019 | 2019 | TEL AVIV UNIVERSITY | 55 LEBANON HAIM | TEL AVIV-JAFFA | | 006905904 | | ISR | R01DC011835 | Genomic Approaches to Discovery and Characterization of Genes for Inherited Hearing Loss | 000 | 7 | NIH | 5/9/2019 | $490,140 |
|
| Issue Date FY: 2018 ( Subtotal = $684,928 ) |
| | 2018 | 2018 | TEL AVIV UNIVERSITY | 55 LEBANON HAIM | TEL AVIV-JAFFA | | 006905904 | | ISR | R01DC011835 | Genomic Approaches to Discovery and Characterization of Genes for Inherited Hearing Loss | 001 | 6 | NIH | 5/16/2018 | $513,179 |
| | 2018 | 2018 | TEL AVIV UNIVERSITY | 55 LEBANON HAIM | TEL AVIV-JAFFA | | 006905904 | | ISR | R21EY029450 | Selective Optogenetic Inhibition of Neuropeptide Release | 000 | 1 | NIH | 8/30/2018 | $171,749 |
| | 2018 | 2015 | TEL AVIV UNIVERSITY | 55 LEBANON HAIM | TEL AVIV-JAFFA | | 006905904 | | ISR | R01DC011835 | Genomic Approaches to Discovery and Characterization of Genes for Inherited Hearing Loss | 000 | 5 | NIH | 11/29/2017 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $199,019 ) |
| | 2017 | 2017 | TEL AVIV UNIVERSITY | 55 LEBANON HAIM | TEL AVIV-JAFFA | | 006905904 | | ISR | R01CA172138 | STRESS UNDERMINES IMMUNE STIMULATION: MECHANISMS & BIOLOGICAL SIGNIFICANCE | 000 | 5 | NIH | 5/22/2017 | $199,019 |
|
| Issue Date FY: 2016 ( Subtotal = $199,019 ) |
| | 2016 | 2016 | TEL AVIV UNIVERSITY | ** | TEL AVIV | | | | ISR | R01CA172138 | STRESS UNDERMINES IMMUNE STIMULATION: MECHANISMS & BIOLOGICAL SIGNIFICANCE | 000 | 4 | NIH | 5/23/2016 | $199,019 |
|
| Issue Date FY: 2015 ( Subtotal = $416,173 ) |
| | 2015 | 2015 | TEL AVIV UNIVERSITY | ** | TEL AVIV | | | | ISR | R01CA172138 | STRESS UNDERMINES IMMUNE STIMULATION: MECHANISMS & BIOLOGICAL SIGNIFICANCE | 000 | 3 | NIH | 5/6/2015 | $204,946 |
| | 2015 | 2015 | TEL AVIV UNIVERSITY | ** | TEL AVIV | | | | ISR | R01DC011835 | Genomic Approaches to Discovery and Characterization of Genes for Inherited Hearing Loss | 000 | 5 | NIH | 6/11/2015 | $211,227 |
|
| Issue Date FY: 2014 ( Subtotal = $407,288 ) |
| | 2014 | 2014 | TEL AVIV UNIVERSITY | ** | TEL AVIV | | | | ISR | R01CA172138 | STRESS UNDERMINES IMMUNE STIMULATION: MECHANISMS & BIOLOGICAL SIGNIFICANCE | 000 | 2 | NIH | 5/30/2014 | $193,928 |
| | 2014 | 2014 | TEL AVIV UNIVERSITY | ** | TEL AVIV | | | | ISR | R01DC011835 | Genomic Approaches to Discovery and Characterization of Genes for Inherited Hearing Loss | 000 | 4 | NIH | 6/6/2014 | $213,360 |
|
| Issue Date FY: 2013 ( Subtotal = $524,913 ) |
| | 2013 | 2013 | TEL AVIV UNIVERSITY | RAMAT-AVIV | TEL AVIV | | | | ISR | R21AI096940 | HIGH THROUGHPUT HIGH RESOLUTION PROFILING OF ANTIBODY SPECIFICITIES OF POLYCLONAL | 000 | 2 | NIH | 1/11/2013 | $125,186 |
| | 2013 | 2013 | TEL AVIV UNIVERSITY | RAMAT-AVIV | TEL AVIV | | | | ISR | R01CA172138 | STRESS UNDERMINES IMMUNE STIMULATION: MECHANISMS & BIOLOGICAL SIGNIFICANCE | 000 | 1 | NIH | 7/22/2013 | $197,034 |
| | 2013 | 2013 | TEL AVIV UNIVERSITY | RAMAT-AVIV | TEL AVIV | | | | ISR | R01DC011835 | Genomic Approaches to Discovery and Characterization of Genes for Inherited Hearing Loss | 000 | 3 | NIH | 6/13/2013 | $202,693 |
|
| Issue Date FY: 2012 ( Subtotal = $376,416 ) |
| | 2012 | 2012 | TEL AVIV UNIVERSITY | RAMAT-AVIV | TEL AVIV | | | | ISR | R21AI096940 | HIGH THROUGHPUT HIGH RESOLUTION PROFILING OF ANTIBODY SPECIFICITIES OF POLYCLONAL | 000 | 1 | NIH | 2/10/2012 | $163,056 |
| | 2012 | 2012 | TEL AVIV UNIVERSITY | RAMAT-AVIV | TEL AVIV | | | | ISR | R01DC011835 | Genomic Approaches to Discovery and Characterization of Genes for Inherited Hearing Loss | 000 | 2 | NIH | 5/18/2012 | $213,360 |
|
| Issue Date FY: 2011 ( Subtotal = $398,486 ) |
| | 2011 | 2011 | TEL AVIV UNIVERSITY | RAMAT-AVIV | TEL AVIV | | | | ISR | R01DC011835 | Genomic Approaches to Discovery and Characterization of Genes for Inherited Hearing Loss | 000 | 1 | NIH | 6/30/2011 | $212,500 |
| | 2011 | 2011 | TEL AVIV UNIVERSITY | RAMAT-AVIV | TEL AVIV | | | | ISR | R01CA125456 | PSYCHONEUROIMMUNOLOGY-IMMUNOTHERAPY INTERACTIONS | 000 | 5 | NIH | 7/26/2011 | $185,986 |
|
| Issue Date FY: 2010 ( Subtotal = $191,737 ) |
| | 2010 | 2010 | TEL AVIV UNIVERSITY | RAMAT-AVIV | TEL AVIV | | | | ISR | R01CA125456 | PSYCHONEUROIMMUNOLOGY-IMMUNOTHERAPY INTERACTIONS | 000 | 4 | NIH | 8/26/2010 | $191,737 |
|
| Issue Date FY: 2009 ( Subtotal = $187,978 ) |
| | 2009 | 2009 | TEL AVIV UNIVERSITY | RAMAT-AVIV | TEL AVIV | | | | ISR | R01CA125456 | PSYCHONEUROIMMUNOLOGY-IMMUNOTHERAPY INTERACTIONS | 000 | 3 | NIH | 7/14/2009 | $187,978 |
|
| Issue Date FY: 2008 ( Subtotal = $182,503 ) |
| | 2008 | 2008 | TEL AVIV UNIVERSITY | ** | TEL AVIV | | 00000 | | ISR | R01CA125456 | PSYCHONEUROIMMUNOLOGY-IMMUNOTHERAPY INTERACTIONS | 000 | 2 | NIH | 7/24/2008 | $182,503 |
|
| Issue Date FY: 2007 ( Subtotal = $180,696 ) |
| | 2007 | 2007 | TEL AVIV UNIVERSITY | ** | TEL AVIV | | 00000 | | ISR | R01CA125456 | PSYCHONEUROIMMUNOLOGY-IMMUNOTHERAPY INTERACTIONS | 000 | 1 | NIH | 8/13/2007 | $180,696 |
|
| Issue Date FY: 2006 ( Subtotal = $385,464 ) |
| | 2006 | 2006 | TEL AVIV UNIVERSITY | ** | TEL AVIV | | 00000 | | ISR | R01CA113473 | SYNTHETIC LETHALITY BASED ASSAY FOR HTS DRUG DISCOVERY | 000 | 2 | NIH | 3/7/2006 | $166,630 |
| | 2006 | 2006 | TEL AVIV UNIVERSITY | ** | TEL AVIV | | 00000 | | ISR | R01GM068493 | G-PROTEIN ALPHA SUBUNITS IN REGULATION OF GIRK CHANNELS | 000 | 4 | NIH | 8/1/2006 | $166,103 |
| | 2006 | 2006 | TEL AVIV UNIVERSITY | ** | TEL AVIV | | 00000 | | ISR | R03CA113252 | AMINOGLYCOSIDE INDUCED RESTORATION OF WILD TYPE APC | 000 | 2 | NIH | 3/1/2006 | $52,731 |
|
| Issue Date FY: 2005 ( Subtotal = $764,740 ) (Continued on the next page) |
| | 2005 | 2005 | TEL AVIV UNIVERSITY | ** | TEL AVIV | | 00000 | | ISR | R01NS031763 | ATAXIA-TELANGIECTASIS: FROM GENE BACK TO PHENOTYPE | 000 | 11 | NIH | 1/18/2005 | $225,000 |
|
